XNAS: ESLA
Estrella Biopharma Inc Live Stock Price Today, Share Analysis and Chart
about
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission ...
Read More
1.10
0.02
(1.85%)
54,197
XNAS Volume
XNAS 19 Mar, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Estrella Biopharma Inc is on 20 Mar 2026 for the purpose of Estrella Immunopharma Inc Annual Report for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
Estrella Biopharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..